In our review, we noticed that IL-1β decreased with the administration of the SSRIs escitalopram [191] (one study) and fluoxetine [192,193,194] (three studies) in patients with depression, as well as with ketamine [195] (one study in patients with treatment-resistant depression). The gene discussed is IL1B; the disease is depressive symptom measurement.